Biotechnology firm Biocon on Friday said its board has approved to raise up to Rs 600 crore in one or more tranches on a private placement basis. The company's board has approved issuance of commercial papers up to an amount not exceeding Rs 600 crore in one or more tranches on private placement basis, the company said in a regulatory filing.
It, however, did not disclose reasons for raising the capital.
Add us to your Preferences
Set as your preferred source on Google
ADVERTISEMENT
RECOMMENDED FOR YOU
Biocon Q2 Results: Company Swings Into Profit, Revenue Rises
Q2 Results Today: Bajaj Finserv, RVNL, Tata Power, BSE, Container Corp Among 380+ Firms To Declare Earnings
Tata Power, Biocon, Bharat Forge, Fortis Q2 Results Today — Earnings Estimates
What Supreme Court Changed To Ease Vodafone Idea's Troubles
POPULAR
1
Infosys Announces Share Entitlement Ratio For Rs 18,000-Crore Buyback — Check Key Details
2
Buy, Sell Or Hold: NHPC, Trent, HUL, IRFC, Asian Paints — Ask Profit
3
CNG Supply To Mumbai Gas Pumps Restored, Says Mahanagar Gas
4
Bullet Train's Inaugural Run To Cover 100 Km Between Surat And Vapi In August 2027: Vaishnaw
5